Pluristem Therapeutics Inc.

$1.00-2.91%($-0.03)
TickerSpark Score
42/100
Weak
73
Valuation
45
Profitability
20
Growth
40
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PSTI research report →

Companywww.pluristem.com

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders.

CEO
Yaky Yanay
IPO
2007
Employees
153
HQ
Haifa, IL

Price Chart

-69.88% · this period
$3.41$2.21$1.00Jul 26Jan 24Jul 25

Valuation

Market Cap
$40.85M
P/E
-0.99
P/S
34.88
P/B
-0.54
EV/EBITDA
-1.48
Div Yield
0.00%

Profitability

Gross Margin
36.72%
Op Margin
-1908.63%
Net Margin
-870.11%
ROE
79.27%
ROIC
140.86%

Growth & Income

Revenue
$1.34M · 0.00%
Net Income
$-23,250,000 · 0.00%
EPS
$-3.56 · 0.00%
Op Income
$-23,329,000
FCF YoY
0.00%

Performance & Tape

Beta
1.91

Get TickerSpark's AI analysis on PSTI

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Feb 10, 22Aberman Zamibuy80,616
May 26, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell122,663
May 26, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell22,015
May 27, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell71,775
May 27, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell24,110
May 28, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell70,007
May 28, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell45,000
May 21, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell69,838
May 24, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell79,300
May 25, 21CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPsell261,238

Our PSTI Coverage

We haven't published any research on PSTI yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PSTI Report →

Similar Companies